| Safety and tolerability of ceftazidime–avibactam was similar to that of comparator drugs. |
| Safety data appeared to be consistent with that of historical data for ceftazidime alone. |
| Safety findings were similar between groups within different infections and post-marketing surveillance will continue to define safety in clinical practice. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.